Pseudoginsenoside Rh2 TN2114
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
Pseudoginsenoside Rh2 has cytotoxicity, it induces mitochondrial apoptosis in A549 cells and is responsible for excessive activation of the Ras/Raf/ERK/p53 pathway. (20Z) -Pseudoginsenoside Rh2 and (20E)-Pseudoginsenoside Rh2 have antioxidative activity.
CAS nr:
1370264-16-6
Purity:
98%
Molecular Weight:
622,88
SMILES:
[H][C@@]12[C@H](CC[C@@]1(C)[C@]1(C)CCC3C(C)(C)[C@@H](CC[C@]3(C)[C@@]1([H])C[C@@H]2O)O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)C(\C)=C\CCC(C)(C)O
Formula:
C36H62O8
Pathway:
MAPK,Apoptosis,MAPK
Target:
Raf,p53,ERK
